The selection process resulted in a nice line-up of Europe

- Arthur Franken, Partner, Gilde Healthcare Partners, Netherlands

I attend many of these types of events. I was very impressed with the quality of the companies that presented. The selection committee clearly had some exceptional companies to choose from and the summit attracted a blue chip group of investors. Overall, an exceptional event!

- Brett Johnson, President & Executive Editor, OneMedPlace.com, USA

We highly appreciated the first ETT MedTech Summit. It is a great initiative which offered a lot of value to all stakeholders involved. Thanks to the great efforts by the selection committee and the selection process, the event is very efficient both for the companies and the investors. We were extremely happy to sponsor the event with Swiss Medtech and SIX Swiss Exchange and to get such a great and personal exposure to this unique and high quality group of medtech companies and investors.

- Yvonne Gunsch-Wegmann, VP, SIS Swiss Exchange, Switzerland

It turned out to be an excellent event. This will be the way we will move the European MedTech start ups on the global map. The interaction and informal exchange of the corporate people, together with the start ups was of extraordinarily high value. The selection and presentations of the companies were very good, and we have set up three follow up meetings with companies, which presented there. We will definitely return next time.

- Thom Rasche, Partner, Earlybird Venture Capital, Germany

Innovation is alive and very well in Europe! It was wonderful to meet with fellow entrepreneurs with their sights set on improving medical care and value. I look forward to MedTech 2010!

- Scott Parazynski, Medical Doctor, Inventor & NASA Astronaut, USA

It was a fantastic opportunity to benchmark our current deal flow, identify syndication opportunities and to connect with other members of the life sciences investment community.

- Ena Prosser, Partner, Fountain Healthcare Partners, Ireland

The ETT MedTech Summit was a thoroughly well organised and executed event - for professionals by professionals.

- Per Dybwad, Chairman & CEO, Polytech Advisors, Switzerland

This event provided I very good opportunity to spot companies with their fascinating new solutions.

- Daniel Andris, VP, Swiss Re, Switzerland

Very well organized! Human size event unlike the huge shows we tend to see more and more these days! Very good selection of top notch European medtech companies and great opportunity to network in a friendly atmosphere!

- Jacques Mallet, Auriga Partners, France

From Angiocam's point of view, the MedTech Summit was a crucial experience. We were introduced to the European Medical Network, and we have been able to make beneficial contacts.

- Ingo Krisch, Angiocam

I found the MedTech Tour Summit extremely useful: the high standard of presenting companies at different stages of their business development provided insights into how I need to position Michelson Diagnostics for an investment. I also made contact with several interested investors and advisors, which I am now taking forward.

- Jon Holmes, CEO, Michelson Diagnostics, UK

Coming through this highly selective qualification process was an honour and a valuable exercise for us. The feedback by the professional audience was very encouraging and has led to several high level contacts that will help our company to achieve its globalization milestones, particularly in light of our US market launch planned for next year. It was absolutely worthwhile to come to Montreux and network with top professionals from the international investment and med tech scenes; we are already in a progressive dialog with some of them.

- Manfred Salat, CEO, Lifebridge Medizintechnik, Germany

The ETT MedTech Summit 2008 was a very successful event. While Europe is a vibrant source of medtech innovation, getting the management talents and investors to bring these innovations to commercial products is one of the challenges our continent is facing. The Summit is addressing this challenge very nicely by bringing together the right people to fuel innovation. For Endosense, it has been a valuable experience to present our opportunity to the venture capital community. This has created some contacts and strengthened some others at an important time of our financing cycle.

- Eric LeRoyer, CEO, Endosense, Switzerland

This event was exactly the right fit in terms of quality and quantity of attendees. Sharing experiences with CEOs and at the same time make contacts with industry senior executives and Venture Capital people made this an ideal networking event for me.

- Christof Boehler, CEO, Pantec Biosolutions, Liechtenstein

I found the Summit very valuable. The large number of venture capital firms represented, and the fact that the representatives had a high level of expertise in our sector, meant that not only I, but other companies had an ideal opportunity to present themselves. Also I must say that I was impressed by the quality of the company presentations, and I compliment the selection committee on their selection.

- Michael James, CEO, Fertility Focus, UK